DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

BIBLIOGRAPHY
Aantaa R, Marjamaki A, Scheinin M. Molecular pharmacology
of α 2
-adrenoceptor subtypes. Ann Med, 1995, 27:439–449.
Abell CW, Kwan SW. Molecular characterization of monoamine
oxidases A and B. Prog Nucleic Acid Res Mol Biol, 2001,
65:129–156.
Ahren B. Autonomic regulation of islet hormone secretion:
Implications for health and disease. Diabetologia, 2000,
43:393–410.
Albuquerque EX, Pereira EFR, Alkondon M, Rogers SW.
Mammalian nicotinic acetylcholine receptors: From structure
to function. Physiol Rev, 2009, 89:73–120.
Altschuler SM, Bao XM, Bieger D, et al. Viscerotopic representation
of the upper alimentary tract in the rat: Sensory ganglia
and nuclei of the solitary and spinal trigeminal tracts. J Comp
Neurol, 1989, 283:248–268.
Andresen MC, Kunze DL. Nucleus tractus solitarius: Gateway to
neural circulatory control. Annu Rev Physiol, 1994, 56:93–116.
Arner P, Hoffstedt J. Adrenoceptor genes in human obesity. J
Intern Med, 1999, 245:667–672.
Aunis D. Exocytosis in chromaffin cells of the adrenal medulla.
Int Rev Cytol, 1998, 181:213–320.
Baillie G, Houslay M. Arrestin times for compartmentalized
cAMP signalling and phosphodiesterase-4 enzymes. Curr
Opin Cell Biol, 2005, 17:129–134.
Boehm S, Kubista H. Fine tuning of sympathetic transmitter
release via ionotropic and metabotropic presynaptic receptors.
Pharmacol Rev, 2002, 54:43–99.
Bonner TI. The molecular basis of muscarinic receptor diversity.
Trends Neurosci, 1989, 12:148–151.
Bowman WC, Prior C, Marshall IG. Presynaptic receptors in
the neuromuscular junction. Ann NY Acad Sci, 1990, 604:
69–81.
Brodde OE. β 1
and β 2
adrenoceptor polymorphisms: Functional
importance, impact on cardiovascular disease and drug
responses. Pharmacol Ther, 2008, 117:1–29.
Brodde OE, Bruck H, Leineweber K. Cardiac adrenoceptors:
physiological and pathophysiological relevance. J Pharmacol
Sci, 2006, 100:323–337.
Burnstock G. Purinergic neurotransmission. Semin Neurosci,
1996, 8:171–257.
Burnstock G. P 2X
receptors in sensory neurons. Br J Anaesth,
2000, 84:476–488.
Bylund DB. Subtypes of α 1
- and α 2
-adrenergic receptors. FASEB
J, 1992, 6:832–839.
Carson RP, Robertson D. Genetic manipulation of noradrenergic
neurons. J Pharmacol Exp Ther, 2002, 301:407–410.
Catterall WA. From ionic currents to molecular mechanisms: The
structure and function of voltage-gated sodium channels.
Neuron, 2000, 26:13–25.
Caulfield MP, Birdsall NJ. International Union of Pharmacology:
XVII. Classification of muscarinic acetylcholine receptors.
Pharmacol Rev, 1998, 50:279–290.
Changeux JP, Edelstein SJ. Allosteric receptors after 30 years.
Neuron, 1998, 21:959–980.
Chaudhry FA, Edwards RH, Fonnum F. Vesicular neurotransmitter
transporters as targets for endogenous and exogenous
toxic substances. Annu Rev Pharmacol Toxicol, 2008, 48:
277–301.
Chen H, Ordög T, Chen J, et al. Differential gene expression in
functional classes of interstitial cells of Cajal in murine small
intestine. Physiol Genomics, 2007, 31:492–509.
Chong BS, Mersfelder TL. Entacapone. Ann Pharmacother,
2000, 34:1056–1065.
Cooke HJ. “Enteric tears”: Chloride secretion and its neural regulation.
News Physiol Sci, 1998, 13:269–274.
Costa M, Brookes SJ, Hennig GW. Anatomy and physiology of
the enteric nervous system. Gut, 2000, 47:15–19.
Costa M, Brookes SJ, Steele PA, et al. Neurochemical classification
of myenteric neurons in the guinea-pig ileum.
Neuroscience, 1996, 75:949–967.
DeFea K. β-arrestins and heterotrimeric G proteins: Collaborators
and competitors in signal transduction. Br J Pharmacol, 2008,
153:5298–5309.
Della Rocca GJ, van Biesen T, Daaka Y, et al. Ras-dependent
mitogen-activated protein kinase activation by G protein–
coupled receptors: Convergence of G i
- and G q
-mediated pathways
on calcium/ calmodulin, Pyk2, and Src kinase. J Biol
Chem, 1997, 272:19125–19132.
DeWire SM, Ahn S, Lefkowitz RT, Shenoy SK. β arrestins and
cell signaling. Annu Rev Physiol, 2007, 69:483–510.
Dhein S, van Koppen CJ, Brodde OE. Muscarinic receptors
in the mammalian heart. Pharmacol Res, 2001, 44:
161–182.
Dooley TP. Cloning of the human phenol sulfotransferase gene
family: Three genes implicated in the metabolism of catecholamine,
thyroid hormones and drugs. Chem Biol Interact,
1998, 109:29–41.
Dorn GW, Brown JH. G q
signaling in cardiac adaptation and
maladaptation. Trends Cardiovasc Med, 1999, 9:26–34.
Dowdall MJ, Boyne AF, Whittaker VP. Adenosine triphosphate,
a constituent of cholinergic synaptic vesicles. Biochem J, 1974,
140:1–12.
Drake MT, Shenoy SK, Lefkowitz RJ. Trafficking of G-proteins
coupled receptors. Circ Res, 2006, 99:570–582.
Eglen RM. Muscarinic receptor subtype. Pharmacol Physiol
Prog Med Chem, 2005, 43:105–136.
Eiden LE. The cholinergic gene locus. J Neurochem, 1998,
70:2227–2240.
Eisenhofer G. The role of neuronal and extraneuronal plasma
membrane transporters in the inactivation of peripheral catecholamine.
Pharmacol Ther, 2001, 91:35–62.
Eisenhofer G, Kopin IJ, Goldstein DS. Catecholamine metabolism:
A contemporary view with implications for physiology
and medicine. Pharmacol Rev, 2004, 56:331–349.
Emorine LJ, Marullo S, Briend-Sutren MM, et al. Molecular
characterization of the human β 3
-adrenergic receptor. Science,
1989, 245:1118–1121.
Exley R, Cragg SJ. Presynaptic nicotinic receptors: A dynamic
and diverse cholinergic filter of striatal dopamine neurotransmission.
Br J Pharmacol, 2008, 153:5283–5297.
Ferguson S, Blakely R. The choline transporter resurfaces: New
roles for synaptic vesicles? Mol Interv, 2004, 4:22–37.
Fetscher C, Fleichman M, Schmidt M, et al. M 3
muscarinic
receptors mediate contraction of human urinary bladder. Br J
Pharmacol, 2002, 136:641–643.
Fredholm BB, Ijzerman AP, Jacobson KA, Linden J. Adenosine
receptors. In, The IUPHAR Compendium of Receptor
Characterization and Classification. 2000, pp. 78–87.
215
CHAPTER 8
NEUROTRANSMISSION: THE AUTONOMIC AND SOMATIC MOTOR NERVOUS SYSTEMS